Table 5.

Changes in the levels of ProBNP from baseline to 2 year follow-up -bezafibrate vs placebo-

	Bezafibrate (n = 58)	Placebo (n = 50)
Absolute change
Mean ± SD	120 ± 524	58 ± 307
Median (Interquartile range)	25 (-14–141)	-20 (-102–87)
P = 0.02 (Kruskal-Wallis test, unadjusted)
Percent change
Geometric mean (95% CI)	34.1 (8.0–66.3)	-4.3 (-21.8–17.0)
Median (Interquartile range)	21.9 (-9.0–111.8)	-15.8 (-33.1–46.6)
P = 0.3 (ANCOVA, adjusted for age and baseline ProBNP levels)
P = 0.01 (Kruskal-Wallis test, unadjusted)